{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:23:07Z","timestamp":1787008987879,"version":"build-2736575974"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIAID R56AI187084"],"award-info":[{"award-number":["NIAID R56AI187084"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>(SARS-CoV-2) has infected a large fraction of the human population. Currently, most individuals have developed immunity either through vaccination or natural infection. Despite this, SARS-CoV-2 booster immunizations are still recommended to reduce the risk of reinfections, but there is still limited understanding of how different booster vaccine platforms influence antibody responses. We conducted immunological studies in mice to evaluate the boosting effects of different vaccine platforms on antibody responses. C57BL\/6 mice were first primed with an adenovirus serotype 5 (Ad5) vector vaccine expressing the SARS-CoV-2 spike protein. The mice were then boosted with the same Ad5-based vaccine (homologous boosting) or with a protein-based vaccine (heterologous boosting). Interestingly, the heterologous regimen (Ad5 prime\/Protein boost) elicited higher binding antibody responses, relative to the homologous regimen (Ad5 prime\/Ad5 boost). Similar potentiation of antibody titers was reported when mice were primed with poxvirus or rhabdovirus vectors and then boosted with protein. These findings highlight a potential advantage of protein booster immunizations to potentiate humoral immunity.<\/jats:p>","DOI":"10.1093\/immhor\/vlaf027","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:25:47Z","timestamp":1762032347000},"source":"Crossref","is-referenced-by-count":2,"title":["A viral vector prime and protein boost vaccine regimen elicits higher binding antibody titers than a homologous viral vector prime-boost regimen"],"prefix":"10.1093","volume":"9","author":[{"given":"Bakare","family":"Awakoaiye","sequence":"first","affiliation":[{"name":"Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University , Chicago, IL,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanushree","family":"Dangi","sequence":"additional","affiliation":[{"name":"Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University , Chicago, IL,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Penaloza-MacMaster","sequence":"additional","affiliation":[{"name":"Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University , Chicago, IL,","place":["United States"]},{"name":"Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center , Boston, MA 02215,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"2025110117254455500_vlaf027-B1","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMoa2109072","article-title":"Covid-19 breakthrough infections in vaccinated health care workers","volume":"385","author":"Bergwerk","year":"2021","journal-title":"N Engl J Med"},{"key":"2025110117254455500_vlaf027-B2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41541-021-00292-w","article-title":"SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates","volume":"6","author":"Kyriakidis","year":"2021","journal-title":"NPJ Vaccines"},{"key":"2025110117254455500_vlaf027-B3","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jama.2021.3199","article-title":"SARS-CoV-2 vaccines","volume":"325","author":"Creech","year":"2021","journal-title":"JAMA"},{"key":"2025110117254455500_vlaf027-B4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.chom.2021.06.016","article-title":"The success of SARS-CoV-2 vaccines and challenges ahead","volume":"29","author":"Subbarao","year":"2021","journal-title":"Cell Host Microbe"},{"key":"2025110117254455500_vlaf027-B5","doi-asserted-by":"crossref","first-page":"109664","DOI":"10.1016\/j.celrep.2021.109664","article-title":"Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2","volume":"36","author":"Dangi","year":"2021","journal-title":"Cell Rep"},{"key":"2025110117254455500_vlaf027-B6","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1128\/JVI.02058-12","article-title":"Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors","volume":"87","author":"Penaloza-MacMaster","year":"2013","journal-title":"J Virol"},{"key":"2025110117254455500_vlaf027-B7","doi-asserted-by":"crossref","first-page":"112167","DOI":"10.1016\/j.celrep.2023.112167","article-title":"Pre-existing immunity modulates responses to mRNA boosters","volume":"42","author":"Dangi","year":"2023","journal-title":"Cell Rep"},{"key":"2025110117254455500_vlaf027-B8","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4049\/jimmunol.2400277","article-title":"Breast milk-derived antibodies impair vaccine immunity in suckling mice","volume":"213","author":"Dangi","year":"2024","journal-title":"J Immunol"},{"key":"2025110117254455500_vlaf027-B9","doi-asserted-by":"crossref","first-page":"eabi8635","DOI":"10.1126\/sciimmunol.abi8635","article-title":"Fractionating a COVID-19 Ad5-vectored vaccine improves virus-specific immunity","volume":"6","author":"Sanchez","year":"2021","journal-title":"Sci Immunol"},{"key":"2025110117254455500_vlaf027-B10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"2025110117254455500_vlaf027-B11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-020-2607-z","article-title":"Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques","volume":"586","author":"Mercado","year":"2020","journal-title":"Nature"},{"key":"2025110117254455500_vlaf027-B12","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1038\/s41467-020-17972-1","article-title":"A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge","volume":"11","author":"Wu","year":"2020","journal-title":"Nat Commun"},{"key":"2025110117254455500_vlaf027-B13","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162282","article-title":"Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody","volume":"132","author":"Dangi","year":"2022","journal-title":"J Clin Invest"},{"key":"2025110117254455500_vlaf027-B14","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1038\/s41564-024-01786-8","article-title":"Evolution of SARS-CoV-2 in the murine central nervous system drives viral diversification","volume":"9","author":"Class","year":"2024","journal-title":"Nat Microbiol"},{"key":"2025110117254455500_vlaf027-B15","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110117254455500_vlaf027-B16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/tmi.13876","article-title":"Lassa fever vaccine candidates: a scoping review of vaccine clinical trials","volume":"28","author":"Sulis","year":"2023","journal-title":"Trop Med Int Health"},{"key":"2025110117254455500_vlaf027-B17","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1038\/s41467-020-18077-5","article-title":"An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques","volume":"11","author":"Feng","year":"2020","journal-title":"Nat Commun"},{"key":"2025110117254455500_vlaf027-B18","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1126\/science.1058867","article-title":"Preferential localization of effector memory cells in nonlymphoid tissue","volume":"291","author":"Masopust","year":"2001","journal-title":"Science"},{"key":"2025110117254455500_vlaf027-B19","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178945","article-title":"An attenuated lymphocytic choriomeningitis virus vector enhances tumor control in mice partly via IFN-I","volume":"134","author":"Chung","year":"2024","journal-title":"J Clin Invest"},{"key":"2025110117254455500_vlaf027-B20","doi-asserted-by":"crossref","first-page":"e1007583","DOI":"10.1371\/journal.ppat.1007583","article-title":"TLR4 signaling improves PD-1 blockade therapy during chronic viral infection","volume":"15","author":"Wang","year":"2019","journal-title":"PLoS Pathog"},{"key":"2025110117254455500_vlaf027-B21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1126\/science.aaa2148","article-title":"Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection","volume":"347","author":"Penaloza-MacMaster","year":"2015","journal-title":"Science"},{"key":"2025110117254455500_vlaf027-B22","doi-asserted-by":"crossref","DOI":"10.1172\/JCI183973","article-title":"Delayed reinforcement of costimulation improves the efficacy of mRNA vaccines in mice","volume":"134","author":"Sanchez","year":"2024","journal-title":"J Clin Invest"},{"key":"2025110117254455500_vlaf027-B23","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151969","article-title":"Cross-protective immunity following coronavirus vaccination and coronavirus infection","volume":"131","author":"Dangi","year":"2021","journal-title":"J Clin Invest"},{"key":"2025110117254455500_vlaf027-B24","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1084\/jem.20132577","article-title":"Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection","volume":"211","author":"Penaloza-MacMaster","year":"2014","journal-title":"J Exp Med"},{"key":"2025110117254455500_vlaf027-B25","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1002\/cpim.99","article-title":"Interrogating Adaptive Immunity Using LCMV","volume":"130","author":"Dangi","year":"2020","journal-title":"Curr Protoc Immunol."}],"container-title":["ImmunoHorizons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article-pdf\/9\/10\/vlaf027\/65052912\/vlaf027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article-pdf\/9\/10\/vlaf027\/65052912\/vlaf027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:25:50Z","timestamp":1762032350000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article\/doi\/10.1093\/immhor\/vlaf027\/8307762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,9,17]]}},"URL":"https:\/\/doi.org\/10.1093\/immhor\/vlaf027","relation":{},"ISSN":["2573-7732"],"issn-type":[{"value":"2573-7732","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,9,17]]},"article-number":"vlaf027"}}